Egyptian Physical Therapists' Perceptions of Tele- Rehabilitation

February 10, 2025 updated by: Ebtihal Abdelaal Eissa Ali, Cairo University

Egyptian Physical Therapists' Perceptions of Tele- Rehabilitation: an Online Open Survey on Acceptability, Preferences, and Needs

The healthcare industry has undergone a significant transformation with the integration of digital technologies, and one of the notable advancements in this field is tele-rehabilitation. Tele-rehabilitation, a subset of telehealth, involves the use of digital platforms to deliver physical therapy services remotely. This innovative approach allows healthcare providers to extend their reach, offering therapy to patients who might otherwise face barriers to accessing care,tele-rehabilitation has been recognized for its numerous benefits. It enhances access to physical therapy services, particularly for individuals living in remote or underserved areas. By reducing the need for travel, tele-rehabilitation offers significant convenience to patients, enabling them to receive therapy in the comfort of their homes.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

both male and female age between equale and more 25

Description

  • Must be a licensed physical therapist with at least 3 years of experience practicing in Egypt.
  • Must be 25 years of age or older.
  • Must have access to the internet and be able to complete an online survey.
  • Available to complete all survey-related questions.

Exclusion Criteria:

  • Not currently practicing as a physical therapist.
  • Diagnosed with conditions that impair the ability to complete an online survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
observithional study of this group
observitional of this study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
acceptability
Time Frame: 6 months
questionnaire
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
preferences
Time Frame: 6 month
quthionnaire
6 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
needs
Time Frame: 6 mnoth
quthionnaire
6 mnoth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2025

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

February 10, 2025

First Submitted That Met QC Criteria

February 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 10, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/005612

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acceptability, Preferences, and Needs

Subscribe